Your session is about to expire
β Back to Search
Continuous Glucose Monitoring for Type 1 Diabetes
Study Summary
This trial will test whether or not real-time remote continuous glucose monitoring can improve glycemic control in adolescents with Type 1 Diabetes.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check βYesβ for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Find a Location
Who is running the clinical trial?
Media Library
- I have a skin condition that prevents me from using a CGM device.You have been using continuous glucose monitoring regularly for the month before the study period.I am not taking systemic corticosteroids at the moment.I have received a blood transfusion in the last 3 months.My thyroid condition is stable, and my recent tests are within the normal range.I am not pregnant.I have a high risk of diabetic ketoacidosis due to my Type 1 Diabetes.You are allergic to the adhesive used in continuous glucose monitoring (CGM) devices.I have sickle cell disease or a related blood condition.I have a severe chronic condition that could affect my blood sugar levels.The patient has a significant delay in development or a behavioral issue that could make it hard to take part in the study. If the patient has very severe, uncontrolled depression at the time of joining the study, they cannot take part.I have been diagnosed with type 1 diabetes for over six months.I have type 2, secondary, or cystic fibrosis-related diabetes.My gender or ethnicity does not exclude me from this trial.I have been diagnosed with type 1 diabetes for over six months.You have a smartphone that can use the Dexcom G6 app and has internet access.I am willing to wear a continuous glucose monitor (CGM) and share the data.I am between 13 and 18 years old.I use insulin injections or an insulin pump for my diabetes.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the capacity of this trial in terms of participant recruitment?
"Affirmative. Clinicaltrials.gov hosts data that indicates this investigation is actively seeking participants, which was initially posted on November 1st 2021 and recently revised on September 26th 2022. This trial requires 20 subjects to be recruited from a single location."
May I participate in this clinical trial?
"The qualifications for this medical trial are those with diabetes and an autoimmune disorder, aged between 13 and 18 years old. As of now, the study is recruiting approximately 20 individuals."
Are any further participants being accepted for this research trial?
"Affirmative. The clinical trial is still taking participants - information on the website states that it was initially posted on November 1st 2021 and most recently refreshed on September 26th 2022; 20 people are needed to be enrolled from one medical centre."
Is the demographic of this trial limited to individuals who have surpassed the age of 70?
"As indicated by the protocol, the age range for enrollment in this clinical trial is 13 to 18 years."
Who else is applying?
What state do they live in?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger